CAS: 945976-76-1

LX-1031 is a molecule that has been shown to have insulin sensitizing effects. It has been used in clinical studies for the treatment of carcinoid syndrome, which is characterized by chronic diarrhea and biochemical abnormalities. LX-1031 has also been shown to be effective in reducing symptoms of inflammatory bowel disease and cancer. This drug may work by decreasing the production of serotonin, which is associated with these diseases.

LX-1031 is an effective inhibitor of tryptophan 5-hydroxylase. LX-1031 decreases serotonin (5-HT) synthesis peripherally.

LX-1031